Qi An

655 total citations
32 papers, 450 citations indexed

About

Qi An is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Qi An has authored 32 papers receiving a total of 450 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 8 papers in Cancer Research and 6 papers in Oncology. Recurrent topics in Qi An's work include MicroRNA in disease regulation (5 papers), Peptidase Inhibition and Analysis (3 papers) and Cancer-related molecular mechanisms research (3 papers). Qi An is often cited by papers focused on MicroRNA in disease regulation (5 papers), Peptidase Inhibition and Analysis (3 papers) and Cancer-related molecular mechanisms research (3 papers). Qi An collaborates with scholars based in China, United States and Canada. Qi An's co-authors include Youfu Luo, Tao Yang, Wenliang Qiao, Juan He, Chungen Li, Wenzhuo Jia, Yao Chen, Yong Deng, Jin‐Ling Huo and Dongmei Wang and has published in prestigious journals such as Journal of Clinical Oncology, Circulation Research and Journal of Medicinal Chemistry.

In The Last Decade

Qi An

28 papers receiving 447 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Qi An China 13 267 112 66 50 37 32 450
Weifan Jiang China 11 258 1.0× 34 0.3× 69 1.0× 60 1.2× 21 0.6× 34 441
Hongyuan Shen Singapore 10 177 0.7× 56 0.5× 42 0.6× 51 1.0× 90 2.4× 28 460
Caroline Aquino Moreira-Nunes Brazil 14 295 1.1× 138 1.2× 30 0.5× 116 2.3× 22 0.6× 68 541
Chang‐Ho Ahn United States 14 255 1.0× 56 0.5× 74 1.1× 81 1.6× 16 0.4× 33 452
Ruchi Shukla India 16 439 1.6× 66 0.6× 59 0.9× 72 1.4× 40 1.1× 43 759
Angel Pang Australia 12 235 0.9× 105 0.9× 42 0.6× 32 0.6× 50 1.4× 16 464
Jun Young Jang South Korea 14 330 1.2× 35 0.3× 29 0.4× 54 1.1× 17 0.5× 24 627
Deusdedit Tusubira Uganda 11 391 1.5× 201 1.8× 14 0.2× 63 1.3× 25 0.7× 38 618
Jianxin Cheng China 13 262 1.0× 101 0.9× 71 1.1× 72 1.4× 9 0.2× 37 423

Countries citing papers authored by Qi An

Since Specialization
Citations

This map shows the geographic impact of Qi An's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qi An with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qi An more than expected).

Fields of papers citing papers by Qi An

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Qi An. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qi An. The network helps show where Qi An may publish in the future.

Co-authorship network of co-authors of Qi An

This figure shows the co-authorship network connecting the top 25 collaborators of Qi An. A scholar is included among the top collaborators of Qi An based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Qi An. Qi An is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jiang, Junyao, Siyu Chen, Wei Huang, et al.. (2025). Prevalence and Risk Factors of Multidrug-Resistant <i>Enterococcal</i> Infection in Clinical Dogs and Cats — China, 2018–2021. China CDC Weekly. 7(3). 77–83.
3.
Chen, Junye, Siyang Liu, Yunfei Xue, et al.. (2024). Exosomes From IgE-Stimulated Mast Cells Aggravate Asthma-Mediated Atherosclerosis Through circRNA CDR1as-Mediated Endothelial Cell Dysfunction in Mice. Arteriosclerosis Thrombosis and Vascular Biology. 44(3). e99–e115. 16 indexed citations
4.
Zhou, Zhenyu, Qi An, Wanying Zhang, et al.. (2024). Histamine and receptors in neuroinflammation: Their roles on neurodegenerative diseases. Behavioural Brain Research. 465. 114964–114964. 9 indexed citations
5.
Zhang, Lili, Jian Cui, Qi An, et al.. (2023). Small extrachromosomal circular DNAs as biomarkers for multi‐cancer diagnosis and monitoring. Clinical and Translational Medicine. 13(9). e1393–e1393. 19 indexed citations
6.
Meng, Haiyang, et al.. (2023). Use of Ceftazidime-Avibactam for Suspected or Confirmed Carbapenem-Resistant Organisms in Children: A Retrospective Study. Infection and Drug Resistance. Volume 16. 5815–5824. 7 indexed citations
7.
Cui, Jian, Jinxin Shi, Lei He, et al.. (2023). Associations of exposure to per- and polyfluoroalkyl substances mixture with the numbers of lymph nodes in colorectal cancer patients. Environmental Research. 240(Pt 1). 117529–117529. 8 indexed citations
9.
An, Qi, et al.. (2022). Emerging roles of fatty acid metabolism in cancer and their targeted drug development. European Journal of Medicinal Chemistry. 240. 114613–114613. 22 indexed citations
10.
An, Qi, Xiaofei Shen, Chungen Li, et al.. (2021). Structure-Guided Design of the First Noncovalent Small-Molecule Inhibitor of CRM1. Journal of Medicinal Chemistry. 64(10). 6596–6607. 20 indexed citations
11.
He, Zhangxu, Qi An, Xin Zhang, et al.. (2021). Discovery of novel 4-phenylquinazoline-based BRD4 inhibitors for cardiac fibrosis. Acta Pharmaceutica Sinica B. 12(1). 291–307. 22 indexed citations
12.
Jin, Mingwei, et al.. (2020). PART1 and hsa‐miR‐429‐Mediated SHCBP1 Expression Is an Independent Predictor of Poor Prognosis in Glioma Patients. BioMed Research International. 2020(1). 1767056–1767056. 8 indexed citations
13.
He, Juan, Wenliang Qiao, Qi An, Tao Yang, & Youfu Luo. (2020). Dihydrofolate reductase inhibitors for use as antimicrobial agents. European Journal of Medicinal Chemistry. 195. 112268–112268. 74 indexed citations
14.
An, Qi, Chungen Li, Yao Chen, et al.. (2020). Repurposed drug candidates for antituberculosis therapy. European Journal of Medicinal Chemistry. 192. 112175–112175. 39 indexed citations
15.
Zhao, Jiaming, Qi An, Chaonan Sun, et al.. (2020). Prognostic factors for breast cancer patients with T1–2 tumors and 1–3 positive lymph nodes and the role of postmastectomy radiotherapy in these patients. Breast Cancer. 28(2). 298–306. 7 indexed citations
16.
Mu, Yu, Qi An, Jian Ma, et al.. (2019). Total synthesis and anti-inflammatory evaluation of violacin A and its analogues. Bioorganic Chemistry. 94. 103420–103420. 10 indexed citations
17.
Jin, Mingwei, Qi An, & Lei Wang. (2017). Importance of tuberin in carcinogenesis. Oncology Letters. 14(3). 2598–2602. 4 indexed citations
18.
Fernandez, Conrad V., Elizabeth A. Mullen, Peter F. Ehrlich, et al.. (2015). Outcome and prognostic factors in stage III favorable histology Wilms tumor (FHWT): A report from the Children’s Oncology Group (COG) study AREN0532.. Journal of Clinical Oncology. 33(15_suppl). 10010–10010.
19.
Fernandez, Conrad V., Elizabeth J. Perlman, Elizabeth A. Mullen, et al.. (2015). Clinical outcome and biological predictors of relapse following nephrectomy only for very low risk Wilms tumor (VLR WT): A report from Children’s Oncology Group AREN0532.. Journal of Clinical Oncology. 33(15_suppl). 10023–10023. 6 indexed citations
20.
Zhang, Eryong, et al.. (2008). [The expression of GATA-4 and Nkx2.5 gene in the transformation of Rattus mesenchymal stem cells into cardiomyocytes].. PubMed. 39(6). 882–5. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026